Guinness Atkinson Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-72,510
Closed -$5.13M 62
2017
Q2
$5.13M Hold
72,510
3.34% 19
2017
Q1
$4.92M Hold
72,510
3.29% 19
2016
Q4
$5.19M Buy
72,510
+17,000
+31% +$1.26M 3.52% 15
2016
Q3
$4.39M Hold
55,510
2.73% 18
2016
Q2
$4.63M Hold
55,510
2.9% 17
2016
Q1
$5.1M Hold
55,510
3.15% 16
2015
Q4
$5.62M Hold
55,510
3.26% 8
2015
Q3
$5.45M Sell
55,510
-13,000
-19% -$1.44M 3.47% 14
2015
Q2
$8.02M Hold
68,510
3.69% 1
2015
Q1
$6.72M Buy
68,510
+19,850
+41% +$2.02M 3.03% 21
2014
Q4
$4.59M Buy
48,660
+6,430
+15% +$665K 2.66% 23
2014
Q3
$4.5M Buy
42,230
+8,370
+25% +$820K 2.53% 6
2014
Q2
$2.81M Buy
33,860
+11,740
+53% +$914K 2.08% 24
2014
Q1
$1.57M Sell
22,120
-2,380
-10% -$187K 1.57% 40
2013
Q4
$1.84M Hold
24,500
1.82% 22
2013
Q3
$1.54M Sell
24,500
-4,000
-14% -$239K 1.48% 36
2013
Q2
$1.46M Buy
+28,500
New +$1.49M 1.54% 24

Other funds holding GILD

Guinness Atkinson Asset Management's GILD Position: Q3 2017 in Review

Guinness Atkinson Asset Management sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 72,510 shares — an estimated $5.13M sold.

Guinness Atkinson Asset Management first reported a position in GILD in Q2 2013 and held it in 17 quarters. The position peaked at $8.02M in Q2 2015. 1,504 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Guinness Atkinson Asset Management reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Guinness Atkinson Asset Management sold 72,510 Gilead Sciences shares in Q3 2017, an estimated $5.13M.
  • Guinness Atkinson Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 17 quarters.
  • Guinness Atkinson Asset Management's Gilead Sciences position peaked at $8.02M in Q2 2015.
  • 1,504 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Guinness Atkinson Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.